Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Other Working Capital Changes (2020 - 2025)

RxSight (RXST) has disclosed Other Working Capital Changes for 6 consecutive years, with $881000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes fell 56.62% year-over-year to $881000.0, compared with a TTM value of -$1.2 million through Dec 2025, down 142.99%, and an annual FY2025 reading of -$1.2 million, down 200.17% over the prior year.
  • Other Working Capital Changes was $881000.0 for Q4 2025 at RxSight, up from -$322000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $2.0 million in Q4 2024 and bottomed at -$1.5 million in Q2 2025.
  • Average Other Working Capital Changes over 5 years is $130112.6, with a median of -$116500.0 recorded in 2023.
  • The sharpest move saw Other Working Capital Changes surged 3910.0% in 2021, then crashed 3241.16% in 2025.
  • Year by year, Other Working Capital Changes stood at -$346000.0 in 2021, then soared by 338.15% to $824000.0 in 2022, then surged by 69.17% to $1.4 million in 2023, then soared by 45.7% to $2.0 million in 2024, then crashed by 56.62% to $881000.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for RXST at $881000.0 in Q4 2025, -$322000.0 in Q3 2025, and -$1.5 million in Q2 2025.